_how-the-novel-covid-19-mrna-vaccine-works-124-amirali-banani.jpg "How The Novel COVID-19 mRNA Vaccine Works | Amirali Banani from lymphocyte Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 2 min 11 sec
✓ Published: 26-Apr-2022
✓ Published: 26-Apr-2022
Description:
The new mRNA technology in Vaccinology - developed by Pfizer BioNTech and Moderna - can radically transform how scientists develop vaccines against other mRNA-based pathogenic viruses in the future, and more importantly, this new class of vaccines has proven to be more effective than traditional vaccines - even against multiple viral variants. The future is truly bright in medicine and biotechnology! | All illustrations, presentation design, script, and voiceover produced by Amirali Banani. nCre
The new mRNA technology in Vaccinology - developed by Pfizer BioNTech and Moderna - can radically transform how scientists develop vaccines against other mRNA-based pathogenic viruses in the future, and more importantly, this new class of vaccines has proven to be more effective than traditional vaccines - even against multiple viral variants. The future is truly bright in medicine and biotechnology! | All illustrations, presentation design, script, and voiceover produced by Amirali Banani. nCre
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_cytotoxic-t-lymphocyte-cell-therapy-directed-against-ebv-ptld-in-the-central-nervous-system.webp "Prof Mohamad Mohty speaks to ecancer at ASH 2018 about a study looking into cell therapy using cytotoxic T lymphocytes to treat EBV PTLD in the central nervous system.nnHe explains that, until now, if the usual treatment was not a success there has been no viable second option.nnProf Mohty reveals that the results of the study have shown a significant response rate of over 60% and also a. number of complete remissions.nnSign up to ecancer for free to receive tailored email alerts for more videos")
⏲ 1 min 61 sec ✓ 03-Dec-2018
_cancer-immunotherapy-adaptive-cell-innate-cell-time-su-hyung-park-korea-advanced-institute-of-science-and-technology.webp "Understanding of Immune Checkpoint Inhibitors in Cancer PatientsnSu-Hyung Park, Korea Advanced Institute of Science and TechnologynnImmuno-oncology drugs are considered as a breakthrough in cancer treatment because of their ability to target and enable immune cells to destroy cancer cells. The immune system is the body’s natural defense system, attacking dangerous cells and destroy them. Cancer cells have developed the ability to ‘hide’ from the immune system and thereby prevent an immune")
⏲ 16 min 24 sec ✓ 18-Jun-2019
_serum-and-synovial-fluid-neutrophil-to-lymphocyte-ratio-nlr--novel-biomarkers-for-the-diagnosis-and-prognosis-of-nativ.webp "Serum and Synovial Fluid Neutrophil-to-Lymphocyte Ratio (NLR)_ Novel Biomarkers for the Diagnosis and Prognosis of Native S from lymphocyte")
⏲ 2 min 51 sec ✓ 18-Jun-2020
_girard-jptumor-associated-high-endothelial-venules-mediate-lymphocyte-entry-into-tumors-and-predict-response-to-pd-1-plu.webp "GIRARD, JPTumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA- from lymphocyte")
⏲ 8 min 99 sec ✓ 16-May-2022
_gofundme-on-bbc-look-north-ian-pinches.webp "As part of our work with GoFundMe, the world’s most popular fundraising website, the Rooster team secured a slot on BBC Look North for Ian Pinches, a Cumbrian man suffering from a rare form of cancer known as Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).n nThis is the second time that cancer has struck for Ian who has now been told it is a lifelong condition and will require treatment for the rest of his life. Ian is hoping to fund potentially life-saving cancer treatment, after lau")
_unbreakable-spirit-conquering-cancer-with-holistic-healing.webp "Get ready to be inspired by the extraordinary journey of Cortney Campbell, a Stage II Nodular Lymphocyte Predominant Hodgkin’s Lymphoma survivor. When faced with limited conventional treatment options back in 2008, Cortney and her husband Kevin made courageous choices, opting for alternative holistic therapies. In this heartfelt interview, join James Templeton as he explores Cortney's path to healing, which includes a mostly raw living foods diet, the Budwig Protocol, targeted supplements, Ess")
_cyrex-92.webp "Cyrex \ from lymphocyte")
_a-cytotoxic-t-lymphocyte-ctl-attacking-a-cancer-cell.webp "A cytotoxic T lymphocyte (CTL) attacking a cancer cell from lymphocyte")
_cytotoxic-t-lymphocyte-cell-therapy-directed-against-ebv-ptld-in-the-central-nervous-system.jpg)
_cancer-immunotherapy-adaptive-cell-innate-cell-time-su-hyung-park-korea-advanced-institute-of-science-and-technology.jpg)
_serum-and-synovial-fluid-neutrophil-to-lymphocyte-ratio-nlr--novel-biomarkers-for-the-diagnosis-and-prognosis-of-nativ.jpg)
_girard-jptumor-associated-high-endothelial-venules-mediate-lymphocyte-entry-into-tumors-and-predict-response-to-pd-1-plu.jpg)
_gofundme-on-bbc-look-north-ian-pinches.jpg)
_unbreakable-spirit-conquering-cancer-with-holistic-healing.jpg)
_cyrex-92.jpg)
_a-cytotoxic-t-lymphocyte-ctl-attacking-a-cancer-cell.jpg)
![[+]](/images/menu.gif){kind=small}